LFST:NSD-Lifestance Health Group Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 6.92

Change

0.00 (0.00)%

Market Cap

USD 2.67B

Volume

1.70M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-15 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

N/A

USD 7.42B
OPCH Option Care Health Inc

N/A

USD 5.52B
SGRY Surgery Partners Inc

N/A

USD 3.06B
AMED Amedisys Inc

N/A

USD 3.02B
ACHC Acadia Healthcare Company Inc

N/A

USD 2.79B
ADUS Addus HomeCare Corporation

N/A

USD 1.74B
ASTH Astrana Health Inc

N/A

USD 1.21B
AVAH Aveanna Healthcare Holdings In..

N/A

USD 0.82B
HCSG Healthcare Services Group Inc

N/A

USD 0.78B
CCRN Cross Country Healthcare Inc

N/A

USD 0.55B

ETFs Containing LFST

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.11% 53% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.11% 53% F 48% F
Trailing 12 Months  
Capital Gain 8.81% 89% A- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.81% 89% A- 68% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -7.46% 44% F 24% F
Dividend Return -7.46% 44% F 24% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 30.76% 67% D+ 61% D-
Risk Adjusted Return -24.26% 44% F 22% F
Market Capitalization 2.67B 80% B- 82% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector